Get your news from a source that’s not owned and controlled by oligarchs. Sign up for the free Mother Jones Daily. The Trump administration formally withdrew that rule on Tuesday, allowing pharmacists ...

EQUASHIELD’s groundbreaking Mundus Compounding System sets a new standard in safety, workflow efficiency, and USP-ready compliance. Modular hazardous drug compounder sets a new standard in safety, ...

PORT WASHINGTON, N.Y., Dec. 3, 2025 /PRNewswire/ -- EQUASHIELD ®, a global leader in Closed System Transfer Devices (CSTD) and pharmacy automation, will highlight its fully integrated hazardous drug ...

No significant differences were seen in diastolic blood pressure, augmentation index, DAS28-CRP. Arduino A. Mangoni, M.D., Ph.D., from Flinders University in Australia, and colleagues conducted a ...

At week 24, no significant difference in PASDAS was observed between the golimumab and methotrexate group and the placebo and methotrexate group. More participants in the placebo and methotrexate ...

Methotrexate significantly reduced systolic blood pressure among patients with rheumatoid arthritis. HealthDay News — For patients with rheumatoid arthritis (RA), methotrexate significantly reduces ...

No significant differences were seen in diastolic blood pressure, augmentation index, DAS28-CRP. HealthDay News — For patients with rheumatoid arthritis (RA), methotrexate significantly reduces ...

CellSHIELD ® addresses critical challenges in cell and gene therapy manufacturing by reducing cost, improving efficiency, and supporting product safety. Its fully closed design ensures sterility and ...